Gene editing (or genome editing) allows scientists to improve the genetics of plants and animals by making small, intentional tweaks to DNA which unlock natural health and disease resistance traits. Gene editing uses genes already native to the plant or animal.
Numerous technological advances over the last decade make it possible to modify animal genomes accurately and efficiently. We use the gene editing tools TALENs and CRISPR/Cas9 to help us intentionally cut and paste the genetic code in the proper place to make the desired change in livestock and fish stock. Our company primarily uses TALENs, an established and proven tool.
Gene editing is tested at various stages along its development cycle from the first cell to the end-product. Our research is overseen by a variety of governmental (like the FDA or USDA) and non-governmental agencies to ensure our compliance with all state and federal/national policies, guidelines, and industry best practices. When working with our international partners, we honor and follow the laws and regulations of all countries where we do business. We take extraordinary measures to ensure the safe and humane treatment and the animals with we work.
Our scientists use this technology to develop and deploy applications for healthier humans through our biomedicine subsidiaries, Surrogen and Regenevida, and healthier animals through our agriculture subsidiary, Acceligen.
Gene editing in biomedicine allows for more advanced animal models for studying human diseases and for testing and developing safer and more effective therapeutics.
Recombinetics deploys gene editing through two biomedicine subsidiaries: Surrogen and Regenevida.
Surrogen helps preclinical researchers study and evaluate the efficacies of therapeutics through its precise pig models of life-threatening human conditions such as neurodegenerative diseases, heart disease, diabetes, and cancer.
Regenevida will enable the most precise possible resolution to human illness through the ability to provide patients with tissue and organ transplantation created using their own cells.
Gene editing used in agriculture enables improved animal welfare, lessened use of antibiotics and improved environmental stewardship through lower greenhouse gas outputs and decreased use of natural resources.
Recombinetics deploys gene editing in agriculture and aquaculture through its subsidiary Acceligen.
Acceligen is the world leader in what is often referred to as “precision breeding”, which is a faster, more precise way to deliver the benefits of crossbreeding. Precision breeding is the next step of the ever-evolving improvement of plants and animals used food honed over thousands of years of farm animal husbandry.